New data suggest venetoclax may offset the negative prognostic impact of short telomeres in patients with chronic lymphocytic leukemia (CLL). A pair of studies examining the role of venetoclax ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback